首页> 外文期刊>Mediators of inflammation >Herbal Extract SH003 Suppresses Tumor Growth and Metastasis of MDA-MB-231 Breast Cancer Cells by Inhibiting STAT3-IL-6 Signaling
【24h】

Herbal Extract SH003 Suppresses Tumor Growth and Metastasis of MDA-MB-231 Breast Cancer Cells by Inhibiting STAT3-IL-6 Signaling

机译:草药提取物SH003通过抑制STAT3-IL-6信号传导抑制MDA-MB-231乳腺癌细胞的肿瘤生长和转移

获取原文
获取原文并翻译 | 示例
       

摘要

Cancer inflammation promotes cancer progression, resulting in a high risk of cancer. Here, we demonstrate that our new herbal extract, SH003, suppresses both tumor growth and metastasis of MDA-MB-231 breast cancer cells via inhibiting STAT3-IL-6 signaling path. Our new herbal formula, SH003, mixed extract from Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii Maximowicz, suppressed MDA-MB-231 tumor growth and lung metastasis in vivo and reduced the viability and metastatic abilities of MDA-MB-231 cells in vitro. Furthermore, SH003 inhibited STAB activation, which resulted in a reduction of IL-6 production. Therefore, we conclude that SH003 suppresses highly metastatic breast cancer growth and metastasis by inhibiting STAT3-IL-6 signaling path.
机译:癌症发炎会促进癌症进展,从而导致患癌的高风险。在这里,我们证明了我们的新草药提取物SH003通过抑制STAT3-IL-6信号通路抑制了MDA-MB-231乳腺癌细胞的肿瘤生长和转移。我们的新草药配方SH003,黄芪,当归和滴虫(Trichosanthes kirilowi​​i Maximowicz)的混合提取物在体内抑制MDA-MB-231肿瘤的生长和肺转移,并降低了MDA-MB-231细胞的存活力和体外转移能力。此外,SH003抑制了STAB活化,从而导致IL-6产生减少。因此,我们得出结论,SH003通过抑制STAT3-IL-6信号通路来抑制高度转移性乳腺癌的生长和转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号